JNJ 6143 Tests Induced Proximity in Prostate Cancer

Company Johnson & Johnson (Halda-derived) Event Type Phase I clinical data, ESMO (source-gap recovery) Modality RIPTAC induced-proximity small molecule Asset JNJ-6143 (HLD-0915) Target Androgen receptor and BRD4 Disease Area Metastatic castration-resistant prostate cancer Summary Source-gap recovery: Johnson & Johnson’s 25 October ESMO Phase I disclosure,…